Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
7m agoSmart Food Packaging Market Report 2026, Competitive Analysis of Amcor, Sonoco Products, Berry Global Group, Sealed Air, Huhtamaki, Mondi, Tetra Pak - Analyst Recommendations and Forecast to 2031
8m agoHunter Nation Applauds Advancement of McCormick Resolution, Championing a Strategic Pause on Restrictive CWD Regulations in Louisiana
8m agoArgo's February Oil Production
9m agoAmerican Rare Earths Strengthens Wyoming Leadership and Project Delivery Team with Key Appointments
9m agoVertical Aerospace to Report Q1 2026 Business & Strategy Update on 6 May 2026
Kezar Life Sciences Inc logo

Kezar Life Sciences Inc

About

Kezar Life Sciences Inc (NASDAQ:KZR) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 12 2026
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
Jan 9 2026
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
Nov 12 2025
Kezar Life Sciences Reports Third Quarter 2025 Financial Results
Nov 7 2025
Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025
Oct 16 2025
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives

Financials

Revenue
$0
Market Cap
$54.55 M
EPS
-7.66

Community Chat

Ask AI

6ix6ix